AQST: Barber Daniel discloses a sale
By AlphaYouPublished Form 4
Barber Daniel
Reporting filer
Barber Daniel reported Sale in Aquestive Therapeutics, Inc.: 25000 units of Common Stock, dated 2026-09-15. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 16, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Barber Daniel | 2026-09-15 | S | Sale | 25000 | 4.8195 | 652,317 | 1 day | Filed terms
|
Common Stock
- Owner
- Barber Daniel
- Date
- 2026-09-15
- Code
- S
- Action
- Sale
- Quantity
- 25000
- Price
- 4.8195
- Following holdings
- 652,317
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- transaction Timeliness:
- transaction Shares: 25000
- transaction Price Per Share: 4.8195
- id: F1
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 652317
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Barber Daniel: President and CEO, Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The reported transaction involves sale transactions from $4.78 to $4.90 per share. The weighted average price per share was $4.8195. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
Original sources
Prepared automatically from public filing data. Report a correction.